Position in AMGN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$2,710,106
+$109,231 QoQ
Shares Held
7,484
+1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.54%
of 13F equity value
Holder Rank
#1,114
of 3,140 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IAM Advisory, LLC holds $17,989,599 across 8 Drug Manufacturers - General names. AMGN ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,638 | $5,562,956 | |
| 2 | MRK |
Merck & Co., Inc.
|
23,515 | $3,021,677 | |
| 3 | AMGN |
Amgen Inc
This page
|
7,484 | $2,710,106 | |
| 4 | NVS |
Novartis AG
|
16,635 | $2,607,037 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
33,075 | $1,905,781 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
11,409 | $1,441,413 | |
| 7 | JNJ |
Johnson & Johnson
|
1,535 | $389,843 | |
| 8 | ABBV |
AbbVie Inc.
|
1,394 | $350,786 |
All Filings in AMGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,710,106 | 7,484 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $2,600,875 | 7,392 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $2,440,423 | 7,456 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $2,104,083 | 7,456 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $2,036,557 | 7,294 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $2,218,236 | 7,120 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,857,841 | 7,128 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $2,261,591 | 7,019 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $2,193,711 | 7,021 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,967,210 | 6,919 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,953,063 | 6,781 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,777,578 | 6,614 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,419,373 | 6,393 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,449,049 | 5,994 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $1,418,256 | 5,400 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $1,173,207 | 5,205 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,167,353 | 4,798 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $1,113,339 | 4,604 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $998,191 | 4,437 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $831,886 | 3,912 | Shares | Sole | 2021-10-14 | |
| 2021-03-31 | $886,510 | 3,563 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $775,980 | 3,375 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||